Spotlight Growth
No Result
View All Result
Monday, July 4, 2022
  • Login
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Bio/Med/Pharma

4 Stocks to Watch as Monkeypox Outbreak Slowly Continues

While medical officials state the odds of a COVID-19-level outbreak of monkeypox is extremely low, cases continue to slowly increase in the U.S. and internationally

by admin
June 7, 2022
in Bio/Med/Pharma, Opinion
0
4 Stocks to Watch as Monkeypox Outbreak Slowly Continues Spotlight Growth

4 Stocks to Watch as Monkeypox Outbreak Slowly Continues Spotlight Growth

Well, here we (maybe) go again.  A mysterious illness is infecting people across the globe and people and governments are scrambling to formulate a response.  Those of us that have been around for a while have seen this scenario play out several times under many names like SARS, Ebola, Swine Flu, Bird Flu, and most recently COVID.  Responses to these maladies have ranged from vague indifference to shutting the world down for two years.  For savvy investors, however, anytime there is panic running rampant, there are also opportunities for those who know where to look.

Prevention and treatment are two main avenues to consider when looking for stocks that could see an upside from a broad monkeypox outbreak.  As the COVID pandemic has taught us, the prevention avenue can be extremely profitable for companies that make vaccines.  Two companies working on monkeypox vaccines include GeoVax Labs (NASDAQ: GOVX) and Emergent BioSolutions (NYSE: EBS).  GeoVax is working on a vaccine that is based on a technology called modified vaccinia Ankara (MVA) which has demonstrated efficacy and safety.  The company is attempting to combine its monkeypox vaccine with the COVID vaccine it is currently in phase 2 trials with that can be used by patients who are immunocompromised.

Source: US CDC
Source: US CDC

Emergent Biosolutions offers a one-two punch play on fighting monkeypox.  The company has received FDA approval for its smallpox vaccine called ACAM2000, and recently acquired a monkeypox therapeutic antiviral treatment from Chimerix (NASDAQ: CMRX) called Tembexa in a $337.5 million deal.  The combination of a proven vaccine and an antiviral treatment may give EBS the inside track to becoming the market leader if monkeypox cases rise dramatically across the world.

On the treatment front, a company to keep an eye on is SIGA Technologies (NASDAQ: SIGA) which makes a treatment for monkeypox called TPOXX.  This treatment can be taken either orally, or intravenously for those patients who cannot swallow capsules.  The oral version is approved for use in the U.S., Canada, and Europe and SIGA recently received FDA approval for the intravenous version.  Another catalyst for SIGA is a recent contract from the Department of Defense to purchase $7.5 million of TPOXX.  In addition to monkeypox, TPOXX is approved in Europe for use for cowpox as well as for complications that arise from vaccinations, and several EU nations are currently building stockpiles of the drug.

It is still the very early innings of the monkeypox news so we don’t yet know how serious any outbreaks will become in various parts of the world. As of June 6, 2022, the U.S. Center for Disease Control (CDC) says there are 1,019 confirmed cases of monkeypox across 29 countries. Having a strategy for how to play the news that is yet to come will be beneficial for investors.  Adding companies like GeoVax Labs, Emergent Biosolutions, Chimerix, and SIGA Technologies to the watchlist will help prepared investors be ready to move on both the prevention and treatment fronts.

Disclosure: No position. Spotlight Growth has no relationships with any of the companies mentioned in this article and did not receive payment in any form for its creation. This is an opinion article and is not meant to be financial advise. We are not broker-dealers or investment professionals. Please conduct your own due diligence. For more information on our disclosures, please visit: https://spotlightgrowth.com/disclosures/

Tags: biopharmaceuticalsbiotechcommon stockday traderday tradingemerging growthinvestinginvesting newsinvestmentmedicalmicrocap stocksmonkeypoxmonkeypox outbreakmonkeypox stocksmonkeypox vaccineNASDAQnewsNYSEoutbreakpharmaceuticalspublic companysmall cap companiessmall cap stockssmall capsSpotlight GrowthSpotlight Growth Stocksstock marketstocksstocks to tradestocks to watchtechtradingtreatmentwebull wallstreetbets
Plugin Install : Widget Tab Post needs JNews - View Counter to be installed
  • Trending
  • Comments
  • Latest
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

November 22, 2021
Alfi NASDAQ ALF Ridesharing Tablet Rollout Spotlight Growth

Alfi, Inc. (NASDAQ: ALF) Climbs 51% After Entering Into Agreement with Miami-Based Fulfillment & Distribution Center For its Ridesharing Digital Tablet Rollout

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Emergent Health OTC EMGE LOI Fusion Specialty Pharmacy Spotlight Growth

Emergent Health Corp. (OTC Pink: EMGE) Announces LOI to Acquire Fusion Specialty Pharmacy

June 29, 2022
Decibel Therapeutics NASDAQ DBTX Interim Data Phase 1b DB 020 Spotlight Growth

Decibel Therapeutics (NASDAQ: DBTX) Shares Positive Interim Data of its Ongoing Phase 1b Trial of DB-020

June 28, 2022
Ayurcann CSE AYUR OTCQB AYURF July Product Rollout Canada Spotlight Growth

Ayurcann (CSE: AYUR) (OTCQB: AYURF) Prepares for July New Product Rollout as Distribution Expansion Continues Across Canada

June 27, 2022
NeuroSense Therapeutics NASDAQ NRSN Stage III ALS Biomarker Study Spotlight Growth

NeuroSense Therapeutics (NASDAQ: NRSN) Details PrimeC’s Positive Results from Stage III ALS Biomarker Study

June 27, 2022

Recent News

Emergent Health OTC EMGE LOI Fusion Specialty Pharmacy Spotlight Growth

Emergent Health Corp. (OTC Pink: EMGE) Announces LOI to Acquire Fusion Specialty Pharmacy

June 29, 2022
Decibel Therapeutics NASDAQ DBTX Interim Data Phase 1b DB 020 Spotlight Growth

Decibel Therapeutics (NASDAQ: DBTX) Shares Positive Interim Data of its Ongoing Phase 1b Trial of DB-020

June 28, 2022

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us
Spotlight Growth

Copyright © 2021 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2021 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested